Bingo. It would be extremely careless to see Mr. Duffy's hire as an incident. MRK has figured out that immunotherapy is the future and DCVAX is the form of delivering it.
Mr. Duffy could have joined NWBO after top line had revealed efficacy and his move would be hence derisked. The hire , in my view is an MRK's insurance to protect its interest and a way to help to navigate through the regulatory process.
A buy out of NWBO may be already agreed on , meeting LP's price, check waiting for the signature, contingent on positive data to be released soon.
What is next? Upon positive top line data announcement, a MRK offer to acquire DCVAX -L "franchise" would be press releases.
What about DCVA-D? The D-franchise would be spun out to a separate trading vehicle, (evidently there is one) where current shareholders would receive 1 for 10 shares owned, a rollback in effect.
Further, as for MRK to secure interest in D-franchise, MRK would write a cheque, say $100 Mil. for 10-20% working interest with milestone payments defined. THis would give the new NWBO-D immediate valuation of $1B . Wall Street would too participate in capital raise as to let the big interest in , helping to cause.
Now of course , this is all just wild speculation based on observing the scientific developments, the corporate action and, dreaming BIG.
Should Linda , 60 oncologists, DI and Dr. Duffy proved to be nefarious in their actions, we will go to zero.
I have made my bets!
News 
Market Data 
Discover 
